Technical Description
The invention pertains to drug delivery system, specifically a hydrogel-based system for the sustained release of insulin to minimize dosing frequency.
Problems Addressed
- Insufficient Drug Release
- Multiple Daily Injections
- Poor Drug Absorption
- Expensive Method
Tech Features
- Hydrogel-Based System
- Blood Glucose Maintenance
- Enabled Reduce Dosage
- Polymeric Injectable System
- Sustained Therapeutic Effect
- Enhanced Efficacy
Target Audience
- Healthcare Industry
- Biomedical Sector
- Pharmaceutical Industry
Tech ID: P21-1667 TRL 5 Patent Status: Granted Available For Exclusive and Non-exclusive License
